Ning Ren

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Cancer immunology, immunotherapy : CII

Nature communications

Cancer research

Oncogene

Zhongshan Hospital Fudan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhongshan Hospital Fudan University

China

Professor :: Liver surgery

Publications

Chunxiao Liu, Chenhao Zhou, Weiya Xia, Yifan Zhou, Yufan Qiu, Jialei Weng, Qiang Zhou, Wanyong Chen, Ying-Nai Wang, Heng-Huan Lee, Shao-Chun Wang, Ming Kuang, Dihua Yu, Ning Ren, Mien-Chie Hung
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Shaoqing Liu, Jialei Weng, Manqing Cao, Qiang Zhou, Min Xu, Wenxin Xu, Zhiqiu Hu, Minghao Xu, Qiongzhu Dong, Xia Sheng, Chenhao Zhou, Ning Ren
FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma. The oncologist (2024)
Chunxiao Liu, Chenhao Zhou, Weiya Xia, Yifan Zhou, Yufan Qiu, Jialei Weng, Qiang Zhou, Wanyong Chen, Ying-Nai Wang, Heng-Huan Lee, Shao-Chun Wang, Ming Kuang, Dihua Yu, Ning Ren, Mien-Chie Hung
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Wenxin Xu, Jialei Weng, Minghao Xu, Qiang Zhou, Shaoqing Liu, Zhiqiu Hu, Ning Ren, Chenhao Zhou, Ying-Hao Shen
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Wenxin Xu, Jialei Weng, Minghao Xu, Qiang Zhou, Shaoqing Liu, Zhiqiu Hu, Ning Ren, Chenhao Zhou, Ying-Hao Shen
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer research (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Wenxin Xu, Jialei Weng, Minghao Xu, Qiang Zhou, Shaoqing Liu, Zhiqiu Hu, Ning Ren, Chenhao Zhou, Ying-Hao Shen
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Chunxiao Liu, Chenhao Zhou, Weiya Xia, Yifan Zhou, Yufan Qiu, Jialei Weng, Qiang Zhou, Wanyong Chen, Ying-Nai Wang, Heng-Huan Lee, Shao-Chun Wang, Ming Kuang, Dihua Yu, Ning Ren, Mien-Chie Hung
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Wenxin Xu, Jialei Weng, Minghao Xu, Qiang Zhou, Shaoqing Liu, Zhiqiu Hu, Ning Ren, Chenhao Zhou, Ying-Hao Shen
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer immunology, immunotherapy : CII 73 (3) (2024)
Chunxiao Liu, Chenhao Zhou, Weiya Xia, Yifan Zhou, Yufan Qiu, Jialei Weng, Qiang Zhou, Wanyong Chen, Ying-Nai Wang, Heng-Huan Lee, Shao-Chun Wang, Ming Kuang, Dihua Yu, Ning Ren, Mien-Chie Hung
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications 15 (1) (2024)
Jialei Weng, Shaoqing Liu, Qiang Zhou, Wenxin Xu, Minghao Xu, Dongmei Gao, Yinghao Shen, Yong Yi, Yi Shi, Qiongzhu Dong, Chenhao Zhou, Ning Ren
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for immunotherapy of cancer 11 (6) (2023)
Xiao-Lu Ma, Ke-Yu Zhu, Yue-Da Chen, Wei-Guo Tang, Su-Hong Xie, Hui Zheng, Ying Tong, Yan-Chun Wang, Ning Ren, Lin Guo, Ren-Quan Lu
Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma. Oncogene 41 (27) (2022)
Chenhao Zhou, Jialei Weng, Yuan Gao, Chunxiao Liu, Xiaoqiang Zhu, Qiang Zhou, Chia-Wei Li, Jialei Sun, Manar Atyah, Yong Yi, Qinghai Ye, Yi Shi, Qiongzhu Dong, Yingbin Liu, Mien-Chie Hung, Ning Ren
A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma. Journal of clinical and translational hepatology 10 (5) (2022)
Hao Zhan, Jiahao Jiang, Qiman Sun, Aiwu Ke, Jinwu Hu, Zhiqiang Hu, Kai Zhu, Chubin Luo, Ning Ren, Jia Fan, Jian Zhou, Xiaowu Huang
Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma. Gastroenterology research and practice 2017 (2017)

Ning Ren.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ning Ren